• Profile
Close

Local administration of methylcobalamin for subacute ophthalmic herpetic neuralgia: A randomized, phase 3 clinical trial

Pain Practice Jun 09, 2020

Xu G, Zhou CS, Tang WZ, et al. - Researchers examined the efficacy of local methylcobalamin injection for subacute ophthalmic herpetic neuralgia (SOHN) via performing a single‐center randomized controlled study including 105 patients with a pain score of 4 or greater. Participants were administered a combination of methylcobalamin and lidocaine via local injection (LM group,  = 35), intramuscular methylcobalamin and local lidocaine injection (IM group,  = 35), or oral methylcobalamin tablet and lidocaine local injection (OM group,  = 35) for 4 weeks. All groups showed reduction in pain scores, however, the LM group had significantly greater reduction (6.7 at baseline vs 2.8 at endpoint) compared with systemic administration (IM group 6.8 vs 4.9, OM group 6.7 vs 5.1). Further, the LM group had significantly reduced analgesic use (94% at baseline vs. 6% at endpoint) and had higher health‐related quality of life than the systemic groups. In mixed modelling, a lower response to methylcobalamin was observed in correlation with increased age.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay